| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977737A1 Crf antagonistic quino- and quinazolines |
| 02/09/2000 | EP0977736A1 Process for preparing pure flupirtin maleate and its modification a |
| 02/09/2000 | EP0977596A1 Use of papovavirus capsid protein for delivery of genetic material |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0977560A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-kappaB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION |
| 02/09/2000 | EP0977558A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | EP0651652B1 Treatment for sensitive teeth |
| 02/09/2000 | CN1244130A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1243749A Inhibitor |
| 02/09/2000 | CN1243745A Chinese patent medicine for treating headache |
| 02/09/2000 | CN1243744A 芦荟组合物 Aloe composition |
| 02/09/2000 | CN1243723A Quickly-acting antalgic ointment |
| 02/09/2000 | CN1049217C 1,5-benzodiazepine derivatives |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022895 Substituted amino compounds and their use as substances having an analgesic effect |
| 02/08/2000 | US6022889 Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety |
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022880 Substituted pyridylamino indoles |
| 02/08/2000 | US6022878 Inhibitors of rotamase enzyme activity |
| 02/08/2000 | US6022877 Use of (+)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl)ethyl]-4-piperidin emethanol in treating depressive disorders and bipolar disorders |
| 02/08/2000 | US6022875 Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 02/08/2000 | US6022868 Substituted azacyclic or azabicyclic compounds |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/08/2000 | CA2014379C Compounds |
| 02/08/2000 | CA2006387C Xanthine derivatives with adenosine-antagonistic activity |
| 02/03/2000 | WO2000005407A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 02/03/2000 | WO2000005394A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/03/2000 | WO2000005231A1 Fkbp inhibitors |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000005210A1 N,n-substituted cyclic amine derivatives |
| 02/03/2000 | WO2000005196A1 α-AMINO ACID PHENYL ESTER DERIVATIVES |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004912A1 Therapeutic agent for dementia, comprising ginseng extract |
| 02/03/2000 | WO2000004905A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 02/03/2000 | WO2000004895A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999058504A9 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338222A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 02/03/2000 | CA2338209A1 Biphenyl derivatives |
| 02/03/2000 | CA2337945A1 .alpha.-amino acid phenyl ester derivatives |
| 02/03/2000 | CA2337941A1 N,n-substituted cyclic amine compounds |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/02/2000 | EP0976747A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders |
| 02/02/2000 | EP0976745A1 4-tetrahydropyridylpyrimidine derivatives |
| 02/02/2000 | EP0976744A1 Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity |
| 02/02/2000 | EP0976404A2 A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| 02/02/2000 | EP0975761A1 Recombinant human beta interferon with enhanced solubility |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975648A1 Morphine derivatives |
| 02/02/2000 | EP0975639A1 Compounds |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975631A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands |
| 02/02/2000 | EP0975623A2 Indazole amide compounds as serotoninergic agents |
| 02/02/2000 | EP0975621A1 Cell differentiation inducing amide derivatives, their production and use |
| 02/02/2000 | EP0975614A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
| 02/02/2000 | EP0975605A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants |
| 02/02/2000 | EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
| 02/02/2000 | EP0975595A1 Analogs of cocaine |
| 02/02/2000 | EP0975593A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity |
| 02/02/2000 | EP0975365A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
| 02/02/2000 | EP0975358A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 02/02/2000 | EP0975351A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 02/02/2000 | EP0900078B1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system |
| 02/02/2000 | EP0820284B1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 02/02/2000 | EP0804185B1 Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 02/02/2000 | CN1243510A Tricyclicbenzo [3] isoindole and benzo (h) isoquinoline |